About | Free Trial

Last Update

2016-05-02T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Vishwanath Lingappa?

Dr. Vishwanath Lingappa R.

Chief Technology Officer and CoCEO

Prosetta Antiviral Inc

Direct Phone: (415) ***-****       

Email: v***@***.com

Prosetta Antiviral Inc

670 5Th Street

San Francisco, California 94107

United States

Company Description

Prosetta Antiviral, Inc. was founded in 2002 with a mission to become a focused pharmaceutical company creating, developing and commercializing novel antiviral based medicines. The company has enjoyed great success and continues to grow as we expand our p ... more

Find other employees at this company (31)

Background Information

Affiliations

Physiology Professor
University of California , San Francisco

Fellow
American Association for the Advancement of Science

Education

B.A. degree

Swarthmore College

M.D. degree

Cornell University Medical College

Ph.D. degree

The Rockefeller University

Web References (38 Total References)


"We very much look forward to ...

www.biospace.com [cached]

"We very much look forward to the opportunity to augment the Prosetta platform with the experience and guidance of Takeda in this area of CNS therapeutics. We believe that our work with Takeda is just one example of the power of the Prosetta paradigm," stated Vishwanath R. Lingappa, M.D., Ph.D., Founder, Chief Executive and Chief Technology Officer of Prosetta.


"We very much look forward to ...

www.biospace.com [cached]

"We very much look forward to the opportunity to augment the Prosetta platform with the experience and guidance of Takeda in this area of CNS therapeutics. We believe that our work with Takeda is just one example of the power of the Prosetta paradigm," stated Vishwanath R. Lingappa, M.D., Ph.D., Founder, Chief Executive and Chief Technology Officer of Prosetta.


I have been gratified by the ...

www.biospace.com [cached]

I have been gratified by the level of investor interest in supporting our unconventional platform for next-generation drug discovery, with the objective of addressing previously unapproachable diseases and disorders that afflict human and animal health," stated Vishwanath R. Lingappa, M.D., Ph.D., Founder, Chief Technology Officer and Co-CEO of Prosetta.


I have been gratified by the ...

www.biospace.com [cached]

I have been gratified by the level of investor interest in supporting our unconventional platform for next-generation drug discovery, with the objective of addressing previously unapproachable diseases and disorders that afflict human and animal health," stated Vishwanath R. Lingappa, M.D., Ph.D., Founder, Chief Technology Officer and Co-CEO of Prosetta.


I have been gratified by the ...

www.biospace.com [cached]

I have been gratified by the level of investor interest in supporting our unconventional platform for next-generation drug discovery, with the objective of addressing previously unapproachable diseases and disorders that afflict human and animal health," stated Vishwanath R. Lingappa, M.D., Ph.D., Founder, Chief Technology Officer and Co-CEO of Prosetta.

Similar Profiles

Other People with this Name

Other people with the name Lingappa

Ravi Lingappa

Usha Lingappa
Schneider Electric SA

Kumar Lingappa
Capgemini

Raghavendra Lingappa
AT&T Inc.

Usha Lingappa
California Institute of Technology

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory